Pustular psoriasis with adrenal suppression following topical corticosteroids.
D000287:Administration, Topical; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000873:Anthracenes / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008875:Middle Aged; D009392:Nephrectomy; D011244:Pregnadienediols / Q000627:therapeutic use*; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy
D000873:Anthracenes; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011244:Pregnadienediols; D001623:Betamethasone